Recall D-0505-2026

US Class II Ongoing · initiated 2026-04-01

Recalling firm

Wells Pharma of Houston LLC, TX

Product

fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.

Reason for recall

cGMP deviations.

← All recalls